Topics

Charles River Labs to Acquire Citoxlab for $510M, Expanding Early-Stage CRO Activity

10:30 EST 13 Feb 2019 | Genetic Engineering News

Charles River Laboratories said today it agreed to acquire the non-clinical contract research organization Citoxlab for €448 million (approximately $510 million) cash, in a deal intended to expand the buyer’s early-stage CRO activity by expanding its scientific portfolio, global scale, and client base of small- and medium-sized biopharmas. Citoxlab is headquartered in Évreux, France and […]

The post Charles River Labs to Acquire Citoxlab for $510M, Expanding Early-Stage CRO Activity appeared first on GEN - Genetic Engineering and Biotechnology News.

Original Article: Charles River Labs to Acquire Citoxlab for $510M, Expanding Early-Stage CRO Activity

NEXT ARTICLE

More From BioPortfolio on "Charles River Labs to Acquire Citoxlab for $510M, Expanding Early-Stage CRO Activity"

Quick Search

Relevant Topics

Clinical Research Organization
Contract Research Organization (CRO) provide research services outsourced on a contract basis to the pharmaceutical, biotechnology, healthcare and medical device industries: biopharmaceutical development biologic assay development commercial...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...